Real-world safety data is also reassuring
When looking at the data, Mounjaro appears to have a slight edge in terms of total weight lost
More peptide stays free, and the half-life stretches from roughly 12-15 hours for native IGF-1 to about 20-30 hours for IGF-1 LR3
But amidst the buzz surrounding GLP-1 drugs, another player has emerged: allulose
Phase 3 trials, including NCT07232719 and NCT07035093, are currently underway with much larger participant pools
People with those cancers who took liraglutide, pramlintide, dulaglutide, tirzepatide, lixisenatide, or semaglutide were 38 per cent to 50 per cent less likely to see the disease spread than people who took drugs from a different class of diabetes medicines known as gliptins